Exosomes are most used in cancer vaccine development, which exerts dendritic cell‐released major histocompatibility complex (MHC) class I/peptide complexes for efficient CD8+ T cell priming to suppress tumour growth.182, 183. This evidence concerns the gene CD8A and neoplasm.